James V Caruso
CIK 1202770 · View on SEC EDGAR ↗
First SEC filing: Aug. 4, 2015 · Latest: Aug. 4, 2015
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | CLRB | P | 26,040 | $0.01 | $260 | 36,076 Direct | +259.47% | Acquired | 25900.0% (price as of 2026-08-21) |
| May 7, 2026 | CLRB | P | 8,680 | $2.88 | $24,998 | 20,318 Direct | +74.58% | Acquired | -9.7% (price as of 2026-08-21) |
| July 2, 2025 | CLRB | P | 10,000 | $0.01 | $100 | 10,000 Direct | — | Acquired | 25900.0% (price as of 2026-08-21) |
| July 2, 2025 | CLRB | P | 10,000 | $4.99 | $49,900 | 11,638 Direct | +610.50% | Acquired | -47.9% (price as of 2026-08-21) |
| March 4, 2021 | CLRB | S | 46,948 | $0.19 | $8,920 | 0 Direct | — | Acquired | -95.4% (price as of 2026-08-21) |
| March 4, 2021 | CLRB | P | 5,100 | $1.70 | $8,670 | 86,401 Direct | +6.27% | Acquired | -99.5% (price as of 2026-08-21) |
| Dec. 28, 2020 | CLRB | P | 37,037 | $1.35 | $50,000 | 81,301 Direct | +83.67% | Acquired | -99.4% (price as of 2026-08-21) |
| June 5, 2020 | CLRB | P | 10,870 | $0.01 | $109 | 10,870 Direct | — | Acquired | -13.3% (price as of 2026-08-21) |
| June 5, 2020 | CLRB | P | 21,740 | $1.14 | $24,784 | 44,264 Direct | +96.52% | Acquired | -99.2% (price as of 2026-08-21) |
| Nov. 30, 2018 | CLRB | P | 1,000 | $2.28 | $2,280 | 22,354 Direct | +4.68% | Acquired | -99.6% (price as of 2026-08-21) |
| March 12, 2018 | CLRB | S 10b5-1 | 34,000 | $1.20 | $40,800 | 213,548 Direct | -13.73% | Disposed | -99.9% (price as of 2026-08-21) |
| April 20, 2016 | CLRB | P | 46,948 | $0.01 | $469 | 46,948 Direct | — | Acquired | -91.3% (price as of 2026-08-21) |
| April 20, 2016 | CLRB | P | 46,948 | $2.12 | $99,530 | 47,548 Direct | +7824.67% | Acquired | -100.0% (price as of 2026-08-21) |
| Nov. 24, 2015 | CLRB | P | 1,000 | $1.30 | $1,300 | 6,000 Direct | +20.00% | Acquired | -100.0% (price as of 2026-08-21) |
| Nov. 20, 2015 | CLRB | P | 1,000 | $1.16 | $1,160 | 5,000 Direct | +25.00% | Acquired | -100.0% (price as of 2026-08-21) |
| Nov. 19, 2015 | CLRB | P | 2,000 | $1.50 | $3,000 | 4,000 Direct | +100.00% | Acquired | -100.0% (price as of 2026-08-21) |
| Nov. 18, 2015 | CLRB | P | 2,000 | $1.39 | $2,780 | 2,000 Direct | — | Acquired | -100.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 7, 2026 | CLRB | Stock option (right to buy) | Common stock (250,000) | $3.14 | May 28, 2036 | 250,000 | Acquired |
| May 7, 2026 | CLRB | Warrants | Common Stock (26,040) | $2.88 | — | 26,040 | Acquired |
| July 2, 2025 | CLRB | Warrants | Common Stock (10,000) | $5.25 | July 2, 2030 | 10,000 | Acquired |
| Feb. 14, 2025 | CLRB | Stock option (right to buy) | Common Stock (900,000) | $0.29 | Feb. 14, 2035 | 900,000 | Acquired |
| June 14, 2024 | CLRB | Stock option (right to buy) | Common Stock (900,000) | $2.65 | Dec. 15, 2033 | 900,000 | Acquired |
| June 23, 2023 | CLRB | Stock option (right to buy) | Common Stock (261,000) | $1.68 | Jan. 17, 2033 | 261,000 | Acquired |
| Jan. 17, 2023 | CLRB | Stock option (right to buy) | Common Stock (261,000) | $1.68 | Jan. 17, 2033 | 261,000 | Acquired |
| Jan. 25, 2022 | CLRB | Stock option (right to buy) | Common Stock (1,419,000) | $0.55 | Jan. 25, 2032 | 1,419,000 | Acquired |
| March 4, 2021 | CLRB | Series A Warrants | Common Stock | — | April 20, 2021 | 46,948 | Acquired |
| March 4, 2021 | CLRB | Stock option (right to buy) | Common Stock (1,600,000) | $1.74 | March 4, 2031 | 1,600,000 | Acquired |
| June 5, 2020 | CLRB | Series H Warrants | Common Stock (10,870) | $1.21 | June 5, 2025 | 10,870 | Acquired |
| Feb. 3, 2020 | CLRB | Stock option (right to buy) | Common Stock (100,000) | $2.71 | Feb. 3, 2030 | 100,000 | Acquired |
| Jan. 17, 2019 | CLRB | Stock option (right to buy) | Common Stock (75,000) | $1.99 | Jan. 17, 2029 | 75,000 | Acquired |
| Oct. 12, 2018 | CLRB | Stock option (right to buy) | Common Stock (150,000) | $2.61 | Oct. 12, 2028 | 150,000 | Acquired |
| May 12, 2016 | CLRB | Stock option (right to buy) | Common Stock (200,000) | $1.48 | May 12, 2026 | 200,000 | Acquired |
| April 20, 2016 | CLRB | Series A Warrants | Common Stock (46,948) | $3.04 | April 20, 2021 | 46,948 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 4, 2015 | CLRB | Employee Stock Option (right to buy)→ Common Stock (375,000) | 375,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $650,000 | — | — | $2,214,000 | $178,750 | — | — | $3,042,750 |
| 2023 | $600,000 | — | $107,582 | $715,140 | $450,000 | — | $92,418 | $1,965,140 |
| 2022 | $569,250 | — | — | $616,697 | $277,225 | — | — | $1,463,172 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.